<https://www.medicalpress.es/mas-de-un-tercio-de-pacientes-con-leucemia-de-alto-riesgo-responden-a-un-nuevo-farmaco-experimental/#primaryimage>
<http://schema.org/inLanguage>
"es"
<https://www.medicalpress.es/mas-de-un-tercio-de-pacientes-con-leucemia-de-alto-riesgo-responden-a-un-nuevo-farmaco-experimental/>